VIVANZA logo

Vivanza Biosciences Ltd

VIVANZA·BSE·
1.75 +0.01 (+0.57%)
Market Cap7.16 Cr
PE Ratio16.20
Volume21,653
Day High - Low1.80 - 1.74
52W High-Low2.72 - 1.52
DocStoX Score
2.3/10
Poor
Fair Value
Sign in to see
ROE
9.38%
Average
P/E
16.20x
Fair
Debt / Equity
2.00
High
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day1.74
1.80
52W1.52
2.72
DocStoX take

Held back by momentum (0.6).

DocStoX score

Low confidence
2.3
/10
Poor
Quality
Weak
ROE 9.4%
Valuation
Rich
P/E 16.2×
Growth
Steady
Revenue +63.3% 5Y CAGR
Risk
High risk
D/E 2.00
Momentum
Weak
19% of 52-week range

At a glance

Market Cap
₹7 Cr
52W High / Low
₹3 / ₹2
Dividend Yield
0.00%
Promoter Holding
20.02%
EPS (TTM)
₹0.11
Book Value
₹1.09

Key highlights

  • Revenue compounding 63% a year
  • Profit shrinking 26% a year
  • High leverage — debt is 2.0× equity
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Vivanza Biosciences Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.